Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Zavegepant for the Acute Treatment of Migraine
NCT07861412Not yet recruiting
- Sponsor
- American Center for Psychiatry and Neurology
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Open-label, single-arm trial of zavegepant in migraine, sponsored by American Center for Psychiatry and Neurology. Primary endpoint: Percentage of participants reporting pain relief. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
zavegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07861412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07861412.